Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DSOMP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LY3343544
|
|||||
| Synonyms |
LY-3343544; LY 3343544
Click to Show/Hide
|
|||||
| Organization |
Eli Lilly & Co.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 6 Indication(s)
|
|||||
| Antibody Name |
Emibetuzumab
|
Antibody Info | ||||
| Antigen Name |
Hepatocyte growth factor receptor (MET)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||
